Sastasundar Ventures Limited has informed the Exchange about Disclosure under Reg 30 of the SEBI (LODR) Reg - Execution of Share Purchase Agreement by Sastasundar Healthbuddy Limited, material subsidiary of the Company
HEALTHX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.7 pts less than Nifty Microcap 250 and 1.4 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Health X Platform Limited informed the exchange that its material subsidiary Sastasundar Healthbuddy Limited (SHBL) has executed a Share Purchase Agreement on February 25, 2026. Under the SPA, Envision India Fund (Buyer) will acquire 10,13,766 equity shares, representing 4.68% of SHBL's paid-up share capital, from Mitsubishi Corporation (Seller) at Rs. 493.21 per share. Total deal value works out to approximately Rs. 50 crore (Rs. 49,99,99,528.86). After the transaction closes, Mitsubishi Corporation will completely exit as a shareholder of SHBL. The listed company's own shareholding in SHBL is not affected, and the SPA is subject to agreed terms and conditions.
This is a change in minority shareholder composition at the material subsidiary level, not a transaction involving the listed company directly — so no immediate impact on the listed entity's capital structure or earnings. Investors may watch how the entry of Envision India Fund and exit of Mitsubishi influences SHBL's growth direction, but no open offer or share purchase obligation is triggered for the listed company.